Literature DB >> 26844634

Orthopedic Manifestations of Ochronosis: Pathophysiology, Presentation, Diagnosis, and Management.

Joseph A Gil1, Joseph Wawrzynski2, Gregory R Waryasz3.   

Abstract

Ochronotic arthropathy occurs in patients with alkaptonuria, manifesting first in the intervertebral discs of the lumbar spine, with subsequent degeneration most often observed in the knee, hip, and shoulder joints. Efforts at treatment are targeted at minimizing the damaging effects of the underlying metabolic disorder on the articular cartilage. Vitamin E and N-acetyl cysteine are potential therapies because of their scavenging of free radicals and consequent limitation of oxidative damage to joint tissue. Arthroscopy has been found to be an effective diagnostic tool in cases of suspected ochronosis. Arthroplasty performed in patients with ochronotic arthropathy suggests that the procedure is effective in the alleviation of joint pain and the improvement of mobility. Perioperative management of these patients may require more careful consideration pertinent to the associated comorbidities of this disorder.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alkaptonuria; Arthroplasty; Arthroscopy; Ochronosis; Ochronotic arthropathy

Mesh:

Year:  2016        PMID: 26844634     DOI: 10.1016/j.amjmed.2016.01.010

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Sacroiliac joint involvement in ochronotic arthropathy.

Authors:  Tuba Yüce İnel; Ali Balcı; İsmail Sarı
Journal:  Eur J Rheumatol       Date:  2020-09-03

Review 2.  A Mimic of Ankylosing Spondylitis, Ochronosis: Case Report and Review of the Literature.

Authors:  Philip Chu; Maria C Cuellar; Sonali J Bracken; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-05       Impact factor: 4.806

3.  Long-term follow-up of bilateral hip and knee arthroplasty secondary to ochronotic arthropathy.

Authors:  Imran Ilyas; Syed Kashif; Majed F Algashiri; Samar A Rabbani; Sahar S Aldakhil; Omar A Al-Mohrej
Journal:  Arthroplast Today       Date:  2020-02-26

4.  Hip and knee replacement in patients with ochronosis: Clinical experience and literature review.

Authors:  Cesare Meschini; Michele Cauteruccio; Maria Serena Oliva; Giuseppe Sircana; Raffaele Vitiello; Giuseppe Rovere; Francesco Muratori; Giulio Maccauro; Antonio Ziranu
Journal:  Orthop Rev (Pavia)       Date:  2020-06-26

5.  Knee Arthroscopy: A Diagnostic and Therapeutic Tool for Management of Ochronotic Arthropathy.

Authors:  William B Stetson; Stephanie A Morgan; Nicole J Hung; Samuel Polinsky
Journal:  Arthrosc Tech       Date:  2018-10-01

6.  Ochronotic arthropathy-a rare clinical case.

Authors:  André Couto; André Sá Rodrigues; Paulo Oliveira; Manuel Seara
Journal:  Oxf Med Case Reports       Date:  2018-08-28

7.  Disruption of hmgA by DNA Duplication is Responsible for Hyperpigmentation in a Vibrio anguillarum Strain.

Authors:  Veronica Batallones; Jennifer Fernandez; Brett Farthing; Jordan Shoemaker; Keizen Li Qian; Kimberly Phan; Eric Fung; Ashley Rivera; Kevin Van; Francesca de la Cruz; Alexandra J Ferreri; Krystle Burinski; Jackie Zhang; Vicente Lizarraga; Kevin Doan; Kenneth Rocha; German Traglia; Maria S Ramirez; Marcelo E Tolmasky
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

8.  Ochronotic arthritis and ochronotic Achilles tendon rupture in alkaptonuria: A 6 years follow-up case report in China.

Authors:  Lifeng Jiang; Le Cao; Jinghua Fang; Xinning Yu; Xuesong Dai; Xudong Miao
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

9.  Total Knee Arthroplasty in Ochronosis Arthropathy: A Case Report and Systematic Review.

Authors:  Wu Chean Lee; Tong Leng Tan; Ying Ho Chan
Journal:  Case Rep Orthop       Date:  2019-10-09

Review 10.  Musculoskeletal manifestations of alkaptonuria: A case report and literature review.

Authors:  Katherine Wu; Erin Bauer; Gihyun Myung; Meika A Fang
Journal:  Eur J Rheumatol       Date:  2018-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.